Dual morphometrical changes of the deltoid muscle in patients with COPD

Respiratory Physiology and Neurobiology

Volumn 134, Issue 3, 2003, Pages 219-229

  Hernández, Nuria ^a,b   Orozco Levi, Mauricio ^a,b,f   Belalcázar, Viviana ^a,c   Pastó, Meritxell ^d,e   Minguella, Joan ^a,b   Broquetas, Joan M ^a,b   Gea, Joaquim ^a,b  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Unitat de Recerca de Farmacologia   (Spain)

^d Hop Cabinet d'Allergologie P   (France)

^e Centre de Protontherepie d'Orsay   (France)

^f INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Accessory respiratory muscles; Adaptation; Fibre size; Morphometry

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DELTOID MUSCLE; FAST MUSCLE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; LUNG FUNCTION TEST; MALE; MORPHOMETRICS; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE HYPERTROPHY; PRIORITY JOURNAL; SLOW MUSCLE;

EID: 17744408598     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9048(03)00015-6     Document Type: Article

References (46)

1. Alaustré A., Sitges S., Jaurrieta M., Sitges C. Valoración de los parámetros antropométricos de nuestra población. Med. Clin. 78:1982;407-415.
2. American Thoracic Society/European Respiratory Society, 1999. Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med., 159, S1-S40.
3. Aran X., Gea J., Guiu R., Aguar M.C., Sauleda J., Broquetas J.M. Comparison between three different maneuvers for achieving maximal transdiapragmatic pressures. Arch. Bronconeumol. 28:1992;112-115.
4. Banker, B.Q., Engel, A.G., 1994. Variation in diameter of muscle fibres within each fasciculus In: Engel, A.G., Franzini-Armstrong, C. (Eds.), Myology, second ed. Basic Reactions of Muscle vol. 1. McGraw-Hill Inc., London, UK, (Part 2, Chapter 35) pp. 845-847.
5. Banzett R., Topulos G., Leith D.E., Natios C. Bracing arms increases the capacity for sustained hyperpnea. Am. Rev. Respir. Dis. 133:1983;106-109.
6. Bellemare F., Grassino A. Effect of pressure and timing of contraction on human diaphragm fatigue. J. Appl. Physiol. 68:1982;2296-2304.
7. Bernard S., Leblanc P., Whittom F., Carrier G., Jobin J., Belleau R., Maltais F. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 158:1998;629-634.
8. Black L.F., Hyatt B. Maximal respiratory pressures: normal values and relationship to age and sex. Am. Rev. Respir. Dis. 99:1969;696-702.
9. Booth F.W., Thomason D.B. Molecular and cellular adaptations of muscle in response to exercise: perspectives of various models. Physiol. Rev. 71:1991;541-585.
10. Brooke M.H., Engels W.K. The histographic analysis of human muscle biopsies with regard to fibre types. 1. Adult male and female. Neurology. 19:1969;221-233.
11. Casaburi R., Barstow T.J., Robinson T., Wasserman K. Dynamic and steady state ventilatory and gas exchange responses to arm exercise. Med. Sci. Sports Exercise. 24:1992;1365-1374.
12. Celli B.R., Rasulo J., Make B.J. Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruction. N. Engl. J. Med. 314:1986;1485-1490.
13. Daniels M., Worthingham B. Functional Examination of the Muscles. fifth ed. 1985;McGraw-Hill, London.
14. Debigaré R., Côté C.H., Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am. J. Respir. Crit. Care Med. 164:2001;1712-1717.
15. Decramer M., DeBock V., Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 153:1996;1958-1964.
16. Decramer M., Gooselink R., Troosters T., Vercshueren M., Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur. Respir. J. 10:1997;417-423.
17. Decramer M., Gosselink R., Troosters T., Schepers R. Peripheral muscle weakness is associated with reduced survival in COPD (abstract). Am. J. Respir. Crit. Care Med. 157:1998;A19.
18. Dillard T.A., Piantadosi S., Rajagopal K.R. Determinants of maximum exercise capacity in patients with chronic airflow obstruction. Chest. 96:1989;267-271.
19. Dubowitz V., Brooke M.H. Muscle biopsy: a modern approach. Dubowitz V., Brooke M.H. Major Problems in Neurology. 1973;74-85 Saunders, London.
20. Gea J., Pasto M., Carmona M.A., Orozco-Levi M., Palomeque J., Broquetas J. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur. Respir. J. 17:2001;1-7.
21. Gollnik P.D., Armstrong R.B., Salting B., Saubert C.W., Sembrowich W.L., Schepherd R.E. Effect of training on enzyme activity and fibre composition of human skeletal muscle. J. Appl. Physiol. 34:1973;107-111.
22. Gosselink R., Troosters T., Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am. J. Respir. Crit. Care Med. 153:1996;976-980.
23. Gregson J.M., Leathley M.J., Moore A.P., Smith T.L., Sharma A.K., Watkins C.L. Reliability of measurements of muscle tone and muscle power in stroke patients. Age Ageing. 29:2000;223-228.
24. Hamilton A.L., Killian K.J., Suumers E., Jones N.L. Muscle strength, symptom intensity and exercise capacity in patients with cardiorespiratory disorders. Am. J. Respir. Crit. Care Med. 152:1995;2021-2031.
25. Hildebrand I.L., Sylven C., Esbjonrsson M., Hellstrom K., Jansson E. Does chronic hypoxaemia induce transformation of fibre types? Acta Physiol. Scand. 141:1991;435-439.
26. Hurley B.F., Redmond R.A., Pratley R.E., Treuth M.S., Rogers M.A., Goldberg A.P. Effects of strength training on muscle hypertrophy and muscle cell disruption in older men. Int. J. Sports Med. 16:1995;378-384.
27. Intermittent Positive Pressure Breathing Trial Group, 1983. Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease. Ann. Intern. Med. 99, 612-620.
28. Kent B. Functional anatomy of the shoulder complex. Phys. Ther. 51:1971;867-874.
29. Laporta D., Grassino A. Assessment of transdiaphragmatic pressure in humans. J. Appl. Physiol. 58:1985;1469-1476.
30. Méndez R., Ramírez-Sarmiento A., Orozco-Levi M., Borrat X., Broquetas J.M., Gea J. Evidence of deltoid muscle recruitment in COPD patients and the theory of muscle compartments. Am. J. Respir. Crit. Care Med. 161:2000;A519.
31. Orozco-Levi M., Gea J., Sauleda J., Corominas J.M., Minguella J., Aran X., Broquetas J.M. Structure of the latissimus dorsi muscle and respiratory function. J. Appl. Physiol. 78:1995;1132-1139.
32. Orozco-Levi M., Gea J., Lloreta J., Félez M., Minguella J., Serrano S., Broquetas J.M. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur. Respir. J. 13:1999;371-378.
33. Orozco-Levi M., Gea J. Structural changes in the muscles in chronic obstructive pulmonary disease: the compartments theory. Arch. Bronconeumol. 36:2000;95-102.
34. Poole D.C., Lieber R.L., Mathieu-Costello O. Myosin and actin filaments length in diaphragms from emphysematous hamsters. J. Appl. Physiol. 76:1994;1220-1225.
35. Robinson J.D., Lupkiewicz S.M., Palenik L., Lopez L.M., Ariet M. Determination of ideal body weight for drug dosage calculations. Am. J. Hosp. Pharm. 40:1983;1016-1019.
36. Roca J., Sanchís J., Agustí-Vidal A., Rodriguez-Roisin R. Spirometric reference values for a mediterranean population. Bull. Eur. Physiopathol. Respir. 22:1986;217-224.
37. Roca J., Rodríguez-Roisisn R., Cobo E., Burgos F., Pérez J., Clausen J.L. Single breath carbon monoxide diffusing capacity (DLCO) prediction equations for a mediterranean population. Am. Rev. Respir. Dis. 141:1990;1026-1032.
38. Satta A., Migliori C., Spanevello A., Neri M., Bottinelli R., Canepari M., Pellegrino M.A., Reggiani C. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur. Respir. J. 10:1997;2853-2860.
39. Sato Y., Asoh T., Honda Y., Fujimatso Y., Higuchi I., Oizumi K. Morphologic and histochemical evaluation of muscle in patients with chronic pulmonary emphysema manifesting generalized emaciation. Eur. Neurol. 37:1997;116-121.
40. Serres I., Gautier V., Varray A., Préfaut C. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest. 113:1998;900-905.
41. Siafakas N.M., Vermeire P., Pride N.B., Paoletti P., Gibson J., Howard P., Yernault J.C., Decramer M., Higenbottam T., Postma D.S. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). European respiratory society consensus statement. Eur. Respir. J. 8:1995;1398-1420.
42. Strauss M.J., Conrad D., Logerfo J.P., Hudson L.D., Berrgner M. Cost and outcome of care for patients with chronic obstructive lung disease. Analysis by physician speciality. Med. Care. 24:1986;915-924.
43. Tangri S., Woolf C.R. The breathing pattern in chronic obstructive lung disease during performance of some common daily activities. Chest. 63:1973;126-127.
44. The working party. Obesity. A report of the Royal College of Physicians, table 14, p. 26. J.R. Coll. Physicians Lond. 17, 5-65.
45. Whittom F., Jobin J., Simard P.-M., Leblanc P., Simard C., Bernard S., Belleau R., Maltais F. Histochemical and morphological characteristics of vastus lateralis muscle in COPD patients. Med. Sci. Sports Exercise. 30:1998;1467-1474.
46. Wilson S.H., Cooke N.T., Edwards R.H.T. Predicted normal values for maximal inspiratory pressure in caucasian adults and children. Thorax. 39:1984;535-538.